Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
AstraZeneca
Harvard Business School
Cipla
Boehringer Ingelheim
Healthtrust
McKesson
UBS
Johnson and Johnson

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205703

« Back to Dashboard

NDA 205703 describes ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER, which is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER profile page.

The generic ingredient in ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
Summary for 205703
Tradename:ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
Applicant:Hq Spclt Pharma
Ingredient:esmolol hydrochloride
Patents:4
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 205703
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 205703
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703 NDA WG Critical Care, LLC 44567-811 N 44567-811-10
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703 NDA WG Critical Care, LLC 44567-811 N 44567-811-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength2.5GM/250ML (10MG/ML)
Approval Date:Apr 7, 2016TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Jan 12, 2021Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jan 12, 2021Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Mar 15, 2033Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Harvard Business School
Medtronic
Healthtrust
QuintilesIMS
Deloitte
AstraZeneca
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.